Kisspeptin Administration Subcutaneously to Patients With IHH

NCT05896293 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Hypogonadotropic Hypogonadism

Interventions

DRUG: kisspeptin 112-121
DRUG: leuprolide acetate

Sponsor

Stephanie B. Seminara, MD